Core Viewpoint - The article emphasizes the growing importance of ESG (Environmental, Social, and Governance) practices among Chinese beauty companies, highlighting their commitment to sustainable development and social responsibility through innovative practices and reporting [2][3]. Group 1: ESG Practices and Reporting - The "Sustainable Innovation Laboratory" by Southern Metropolis Daily is collaborating with Shanghai University of Finance and Economics to evaluate and recognize outstanding ESG practices among companies, culminating in the release of the "2025 ESG Sustainable Innovation Trend Insight Report" [3]. - Major Chinese beauty companies, including Up Beauty, Proya, and Huaxi Biological, are increasingly focusing on "green packaging" as a key ESG issue, with a consensus emerging on carbon reduction and product circular consumption [3][4]. - Proya has provided detailed disclosures regarding its green packaging initiatives, including a 20% increase in sustainable materials and a 15% reduction in packaging usage intensity [4]. Group 2: Specific Initiatives by Companies - Up Beauty has implemented eight guidelines for sustainable packaging, including using FSC-certified paper and eco-friendly inks, while Huaxi Biological has improved packaging processes to minimize waste [4]. - Beitaini reported a significant increase in its bottle recycling program, achieving 2.67 million bottles recycled in 2024, which is eight times the amount from 2023 [5]. - L'Oréal has committed to ensuring that 100% of its plastic packaging is refillable, reusable, recyclable, or compostable by 2025, promoting refillable options for its products [6]. Group 3: Emerging Trends in ESG Reporting - Chinese beauty companies are beginning to incorporate "Chinese characteristics" into their ESG narratives, such as employee welfare initiatives and rural revitalization projects [7][8]. - The trend of "pure beauty" is gaining traction, with companies focusing on the safety and transparency of product ingredients, responding to consumer demand for cleaner products [14][15]. - Companies are increasingly establishing anti-corruption mechanisms, with some, like Mao Geping, including anti-corruption training in their ESG reports [10]. Group 4: Challenges and Opportunities - There is a notable lack of quantifiable targets in ESG reporting among Chinese beauty companies, particularly regarding greenhouse gas emissions and sustainable sourcing [16][19]. - The complexity of supply chains poses challenges for accurate carbon emission reporting, with many companies struggling to obtain reliable data from suppliers [19]. - The regulatory environment in China is less stringent compared to Western markets, leading to a reliance on voluntary commitments rather than mandatory compliance for ESG goals [19].

Core Viewpoint - The article discusses the decline of Korean cosmetics brands, particularly Sulwhasoo, in the Chinese market, highlighting the rise of domestic beauty brands and changing consumer preferences [1][9]. Group 1: Market Trends - Sulwhasoo plans to close approximately 30 stores in China, primarily in second-tier cities, reflecting a broader struggle for Korean cosmetics brands in the market [3][5]. - From 2022 to 2025, the share of Korean cosmetics in China's online sales is projected to drop from 69% to 23%, while the U.S. market share will increase to 51%, indicating a significant loss of popularity in China [10]. - In 2023, domestic beauty brands surpassed international brands in market share for the first time, with brands like Winona and Fulejia gaining traction due to better understanding of local consumer needs and competitive pricing [12]. Group 2: Consumer Behavior - There has been a shift in consumer purchasing behavior from valuing brand reputation and packaging to focusing on product ingredients and effectiveness [13]. - Consumers are increasingly scrutinizing product ingredient lists, leading to a preference for brands that provide clear information about their formulations and benefits [15]. Group 3: Channel Dynamics - The decline of foot traffic in traditional department stores has negatively impacted brands like Sulwhasoo that rely heavily on physical retail locations [7][19]. - Many leading domestic brands have over 90% of their sales coming from online channels, while Korean brands have been slow to adapt to this shift, missing out on the online sales boom [17][19]. Group 4: Innovation and Adaptation - Korean cosmetics brands are struggling with product innovation and are unable to keep pace with the rapid changes in consumer demand in China [21][23]. - Unlike international giants that invest in local R&D to cater to Chinese consumers, Korean brands like Amorepacific continue to rely on a one-size-fits-all approach, limiting their adaptability [23]. Group 5: Future Outlook - The ongoing store closures may signal a challenging future for Korean brands in China, as they must reconsider their strategies to remain relevant in a highly competitive market [25].

Core Viewpoint - In 2023, Proya surpassed L'Oreal on Tmall's Double 11 list, but after achieving over 10 billion in revenue, it faced significant declines in performance, with Q3 revenue down 11.63% and net profit down 23.64%, marking the largest quarterly drop in recent years [1][41] Company Performance - Proya's revenue for the first half of the year was 39.79 billion yuan, a slight decline of 0.08% year-on-year [1] - The company aims to enter the top ten global cosmetics brands within the next decade under the "Double 10 Strategy" initiated by the new general manager, Hou Yameng [1][41] - Proya's sales expenses reached 35.25 billion yuan in Q3 2025, accounting for 49.66% of revenue, a significant increase from the previous year [17][57] Market Positioning - Proya has been labeled as a "big brand alternative," often compared to L'Oreal, which has helped it penetrate the market but now poses challenges as it seeks to break through its brand ceiling [2][42] - The brand's product matrix follows a pyramid structure similar to L'Oreal, with a focus on mid-to-high-end efficacy skincare [5][45] Consumer Trends - The rise of domestic brands has been supported by a shift in consumer preferences towards value for money, with Proya's products priced between 200-500 yuan appealing to cost-conscious consumers [7][47] - Consumers are increasingly prioritizing product efficacy and ingredient safety over brand prestige, creating opportunities for Proya and other domestic brands [8][48] Challenges Faced - Proya is experiencing a decline in the effectiveness of its core products, with the market becoming saturated and competition intensifying [11][57] - The company's heavy reliance on marketing over research and development has led to a situation where marketing efforts are not translating into sustained product innovation [18][58] - Proya's online sales channel dependency exceeds 95%, limiting its ability to engage with consumers through offline experiences, which are increasingly valued by younger consumers [21][62] Global Expansion Efforts - Proya aims to expand internationally, focusing on markets in Japan and Southeast Asia, but its overseas revenue remains low at only 1.6% of total revenue [35][68] - The brand's high-end product lines and overseas operations are still in the early stages, lacking the scale and maturity of its mainstream offerings [28][68]

Core Viewpoint - Kose Group has recently announced a significant management change in its China operations, appointing Ishii Yasuhiro as the new General Manager starting January 1, 2026, as part of its restructuring and performance recovery strategy for the Chinese market [3][20][25] Group 1: Management Changes - Ishii Yasuhiro, who has extensive experience in the Chinese market, will take over from the current Chairman and General Manager, Shinohara Kazuki, who will return to the headquarters to lead the Consumer Brand division [3][4] - This management change aligns with Kose's long-term strategy for 2030 and reflects the company's commitment to prioritize the Chinese market for global growth [3][20] Group 2: Ishii Yasuhiro's Background - Ishii has a diverse career spanning cosmetics, food, and electronics, with significant roles in Shiseido and other companies, focusing on brand marketing, channel development, and digital transformation in China [6][9] - His fluency in Chinese and deep understanding of local market dynamics position him as a strategic asset for Kose as it seeks to enhance its local operations [9][10] Group 3: Strategic Focus and Market Response - Under Ishii's leadership, Kose aims to solidify Decorte and Sekkisei as its core brands in China, targeting both high-end and mass markets through differentiated strategies [13][17] - The company has reported a rebound in sales in the Chinese market, with a notable increase in online average transaction value by 109% year-on-year, indicating a successful response to market demands [15][18] Group 4: Organizational Transformation - Kose is transitioning to a holding company structure, which will grant greater autonomy to its subsidiaries, including Kose China, enhancing operational efficiency and market responsiveness [20][23] - The new governance structure is designed to align with Kose's long-term vision of becoming a lifelong beauty partner, emphasizing the need for adaptability in a competitive market [23][25]

Core Insights - The AI+ Innovation Technology Conference held in Shanghai focused on how AI can reshape marketing growth, attracting over 200 industry experts and marketing elites, with 82.8% from brand companies and around 40% in senior management positions [1][4]. Group 1: AI in Marketing - The forum discussed various topics including AI's role in reconstructing marketing operations, practical applications in the beauty and maternal industries, and insights into consumer behavior in the AI era [1]. - Deloitte's partner highlighted the expanding breadth and depth of AI applications, emphasizing the need for companies to leverage AI for brand, talent, and data asset development [5]. - Natural brand Chando shared its AI implementation journey, focusing on transforming from traditional models to consumer-facing platforms, and the importance of data governance [6]. Group 2: Industry Challenges and Opportunities - IPG's Chief Strategy Officer discussed the rapid transformation of the marketing ecosystem due to AI, identifying challenges such as talent shortages and data security concerns [8]. - A roundtable discussion featured experts exploring whether AI serves as a cost-reduction tool or a value-creation engine in marketing [13]. - The CEO of AIGC Innovation Base presented on the practical applications of AI in retail, emphasizing the need for internal AI communities to enhance operational efficiency [14][15]. Group 3: Case Studies and Future Directions - The Chief Product Officer of Kidswant detailed the company's digital transformation journey, highlighting the launch of a large language model for the maternal and infant industry [17]. - White Elephant Food Group's design head discussed the evolution of AIGC from a productivity tool to a creative partner, showcasing successful marketing campaigns driven by AI [18]. - The CEO of SenChuang QiRui shared insights on AI's role in e-commerce, presenting solutions for cost reduction and operational efficiency, predicting a new era for AI in the industry [20]. Group 4: Awards and Recognition - The conference concluded with the iDigital Annual Digital Marketing Awards and AI Innovation Awards, recognizing contributions and innovations in the digital marketing and AI sectors over the past year [21].

Group 1 - The recent U.S. national security strategy document sharply criticizes Europe, stating that the continent faces a more severe threat of "civilizational decline" rather than just economic recession, which is unacceptable to traditional European powers [3] - The U.S. has been applying pressure on Europe through tariffs, compelling European nations to seek closer ties with China, as evidenced by recent high-level visits from French President Macron and German Foreign Minister Baerbock [5][12] - The EU's economic report indicates that the U.S. tariffs will negatively impact the Eurozone's growth, particularly in the automotive and chemical sectors, potentially reducing growth by 0.5 percentage points [8] Group 2 - The trade relationship between China and Germany has strengthened, with Germany's trade volume with China reaching €185.9 billion, making China Germany's largest trading partner [8] - French and Chinese companies have engaged in significant collaborations, including joint aircraft development and energy projects, with bilateral trade increasing by 4.1% year-on-year [10] - The shift in European focus towards China is characterized by a desire for equal dialogue and mutual benefits, contrasting with the U.S. approach of threats and sanctions [14]

Core Viewpoint - Marubi Biological has officially initiated its secondary listing process in Hong Kong, aiming to become one of the few domestic beauty giants with an "A+H" market presence, despite facing increased competition in the eye care product segment [1] Company Overview - Established in 2002, Marubi focuses on eye care research and gained prominence in 2007 with its popular eye cream, which helped it become the "first eye cream stock" upon its A-share listing in 2019 [1] - Marubi has maintained its position as the top seller in the eye care market in China for three consecutive years from 2021 to 2023 [1] Financial Performance - In 2024, Marubi reported a revenue of 2.97 billion yuan, representing a year-on-year growth of 33.44% - The net profit attributable to the parent company increased by 31.69% to 342 million yuan [1] Marketing and Brand Structure - The company has relied heavily on marketing for growth, with significant expenditures on advertising and traffic, while its research and development investment is relatively low compared to the industry [1] - The main brands "Marubi" and "Lianhuo" are experiencing growth, but the brand "Chunji" has seen a contraction [1] Competitive Landscape - Competitors such as Proya and Winona have launched similar eye care products, which has led to a squeeze on Marubi's market share [1] Regulatory Issues - In late October, Marubi was ordered to rectify issues related to financial accounting, fundraising management, and disclosure, leading to increased uncertainty regarding its IPO in Hong Kong [1]

Company Overview - Guangdong Marubi Biotechnology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors [1] - Marubi is the third largest beauty company in China's recombinant collagen skincare segment based on retail sales projected for 2024 [1] - The company focuses on providing anti-aging solutions and has over 20 years of experience in the skincare industry, leveraging synthetic biology technology [1] Product Development - Marubi has successfully developed recombinant double collagen, which combines type I (profile) collagen and type III (filling) collagen into a single molecule [1] - The company has established a comprehensive value chain covering basic research to application, having developed over 80 proprietary ingredients, with more than 30 achieving large-scale production [3] Brand Performance - Marubi and its brand "Lianhuo" are the main brands, with Marubi ranking first in China's eye care brand market from 2021 to 2024 based on retail sales [2] - Lianhuo ranks third among domestic foundation brands and fifth among all foundation brands in China, with a compound annual growth rate (CAGR) of 77.5% from 2022 to 2024 [2] Financial Performance - The company recorded revenues of RMB 1.732 billion, RMB 2.226 billion, RMB 2.970 billion, and RMB 2.450 billion for the years 2022, 2023, 2024, and the nine months ending September 30, 2025, respectively [4] - The annual profits for the same periods were RMB 167 million, RMB 278 million, RMB 342 million, and RMB 247 million [5] - Gross profits for the respective years were RMB 1.175 billion, RMB 1.560 billion, RMB 2.177 billion, and RMB 1.834 billion [6] Industry Overview - The Chinese beauty industry is projected to grow from RMB 460.3 billion in 2019 to RMB 566.3 billion in 2024, with a CAGR of 4.2% [7] - The skincare market is expected to grow from RMB 355.9 billion in 2019 to RMB 451.4 billion in 2024, with a CAGR of 4.9% [8] - The makeup market is anticipated to grow from RMB 104.5 billion in 2019 to RMB 114.8 billion in 2024, with a CAGR of 1.9% [9]

Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors, highlighting its position as a leading Chinese beauty company focused on anti-aging solutions [1] Company Overview - Marubi Biotechnology specializes in providing anti-aging skincare solutions and has over 20 years of experience in the industry, driven by synthetic biology technology [1] - The company emphasizes research and development, particularly in core technologies such as recombinant collagen, to innovate skincare products with anti-wrinkle, firming, and repairing effects [1] Market Position - According to a report by Frost & Sullivan, Marubi is the third largest beauty company in China in the segment of recombinant collagen skincare products, based on retail sales projected for 2024 [1]

Core Insights - Mamei Bio is a leading Chinese beauty company focused on anti-aging solutions, leveraging synthetic biology technology and over 20 years of experience in the skincare industry [4][5] - The company has developed a recombinant double collagen, a unique engineered protein that combines type I and type III collagen into a single molecule, enhancing its skincare products [4] - Mamei Bio has been recognized as the primary drafting unit for the national standard of "Recombinant Soluble Collagen" by the Ministry of Industry and Information Technology in 2023 [4] Company Overview - Mamei Bio operates two main brands: Mamei, focusing on anti-aging eye and facial care products, and Lianhuo, a cost-effective makeup brand [4] - The company has established a comprehensive value chain for core ingredients, developing over 80 proprietary components, with more than 30 achieving large-scale production [7] - Mamei Bio's production facilities are located in Guangzhou, China, and are equipped for high-density fermentation and purification processes for recombinant collagen production [7] Financial Performance - Mamei Bio's revenue for the years ending December 31 and the nine months ending September 30 are as follows: RMB 1.732 billion in 2022, RMB 2.226 billion in 2023, RMB 2.977 billion in 2024, and RMB 2.450 billion for the nine months of 2025 [8] - The company's profit for the same periods is reported as RMB 167 million in 2022, RMB 278 million in 2023, RMB 342 million in 2024, and RMB 247 million for the nine months of 2025 [9] - Gross profit figures are RMB 1.175 billion in 2022, RMB 1.560 billion in 2023, RMB 2.177 billion in 2024, and RMB 1.834 billion for the nine months of 2025 [10] Industry Overview - The Chinese beauty market is projected to grow from RMB 460.3 billion in 2019 to RMB 566.3 billion by 2024, with a compound annual growth rate (CAGR) of 4.2% [11] - The skincare segment is expected to expand from RMB 355.9 billion in 2019 to RMB 451.4 billion by 2024, with a CAGR of 4.9% [14] - The makeup segment is anticipated to grow from RMB 104.5 billion in 2019 to RMB 114.8 billion by 2024, with a CAGR of 1.9% [17]